Telomere Length at Diagnosis of Chronic Phase Chronic Myeloid Leukemia (CML-CP) Identifies a Subgroup with Favourable Prognostic Parameters and Molecular Response According to the ELN Criteria After 12 Months of Treatment with Nilotinib

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2015 Sep 16

PMID 26369986

Citations 11

Authors

K Wenn

L Tomala

S Wilop

L Vankann

C Hasenbank

O Frank

A Hochhaus

F J Giles

T Lange

M C Muller

S Koschmieder

F Beier

P Ziegler

T H Brummendorf

Affiliations

Soon will be listed here.

Citing Articles

Advancements in leukemia management: Bridging diagnosis, prognosis and nanotechnology (Review).

Li J, Wang Y, Dong C, Luo L Int J Oncol. 2024; 65(6).

PMID: 39364739 PMC: 11542963. DOI: 10.3892/ijo.2024.5700.

LARP3, LARP7, and MePCE are involved in the early stage of human telomerase RNA biogenesis.

Kao T, Huang Y, Chen Y, Baumann P, Tseng C Nat Commun. 2024; 15(1):5955.

PMID: 39009594 PMC: 11250828. DOI: 10.1038/s41467-024-50422-w.

Telomere biology: from disorders to hematological diseases.

Roka K, Solomou E, Kattamis A Front Oncol. 2023; 13:1167848.

PMID: 37274248 PMC: 10235513. DOI: 10.3389/fonc.2023.1167848.

The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia.

Deregowska A, Pepek M, Solarska I, Machnicki M, Pruszczyk K, Dudzinski M J Cancer Res Clin Oncol. 2023; 149(10):7103-7112.

PMID: 36871092 PMC: 10374722. DOI: 10.1007/s00432-023-04662-w.

Telomere length dynamics measured by flow-FISH in patients with obesity undergoing bariatric surgery.

Rolles B, Ferreira M, Vieri M, Rheinwalt K, Schmitz S, Alizai P Sci Rep. 2023; 13(1):304.

PMID: 36609582 PMC: 9818052. DOI: 10.1038/s41598-022-27196-6.

References

Brummendorf T, Holyoake T, Rufer N, Barnett M, Schulzer M, Eaves C . Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry. Blood. 2000; 95(6):1883-90. View

Brummendorf T, Ersoz I, Hartmann U, Balabanov S, Wolke H, Paschka P . Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemia. Ann N Y Acad Sci. 2003; 996:26-38. DOI: 10.1111/j.1749-6632.2003.tb03229.x. View

Sokal J, Cox E, Baccarani M, Tura S, Gomez G, Robertson J . Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood. 1984; 63(4):789-99. View

Brummendorf T, Ersoz I, Hartmann U, Bartolovic K, Balabanov S, Wahl A . Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia. Blood. 2002; 101(1):375-6. DOI: 10.1182/blood-2002-08-2557. View

Drummond M, Balabanov S, Holyoake T, Brummendorf T . Concise review: Telomere biology in normal and leukemic hematopoietic stem cells. Stem Cells. 2007; 25(8):1853-61. DOI: 10.1634/stemcells.2007-0057. View

Armanios M, Blackburn E . The telomere syndromes. Nat Rev Genet. 2012; 13(10):693-704. PMC: 3548426. DOI: 10.1038/nrg3246. View

Drummond M, Lennard A, Brummendorf T, Holyoake T . Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia. Leuk Lymphoma. 2004; 45(9):1775-81. DOI: 10.1080/10428190410001693542. View

Weidner C, Ziegler P, Hahn M, Brummendorf T, Ho A, Dreger P . Epigenetic aging upon allogeneic transplantation: the hematopoietic niche does not affect age-associated DNA methylation. Leukemia. 2014; 29(4):985-8. DOI: 10.1038/leu.2014.323. View

Ziegler P, Schrezenmeier H, Akkad J, Brassat U, Vankann L, Panse J . Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation. Ann Hematol. 2012; 91(7):1115-20. DOI: 10.1007/s00277-012-1454-x. View

10.

Gutierrez-Rodrigues F, Santana-Lemos B, Scheucher P, Alves-Paiva R, Calado R . Direct comparison of flow-FISH and qPCR as diagnostic tests for telomere length measurement in humans. PLoS One. 2014; 9(11):e113747. PMC: 4237503. DOI: 10.1371/journal.pone.0113747. View

11.

Brummendorf T, Maciejewski J, Mak J, Young N, Lansdorp P . Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood. 2001; 97(4):895-900. DOI: 10.1182/blood.v97.4.895. View

12.

Baccarani M, Deininger M, Rosti G, Hochhaus A, Soverini S, Apperley J . European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 2013; 122(6):872-84. PMC: 4915804. DOI: 10.1182/blood-2013-05-501569. View

13.

Keller G, Brassat U, Braig M, Heim D, Wege H, Brummendorf T . Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy. Hematol Oncol. 2009; 27(3):123-9. DOI: 10.1002/hon.901. View

14.

Hasford J, Pfirrmann M, Hehlmann R, Allan N, Baccarani M, Kluin-Nelemans J . A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group. J Natl Cancer Inst. 1998; 90(11):850-8. DOI: 10.1093/jnci/90.11.850. View